Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis

Fig. 5

Rec-ELISA analysis of IgG1 and IgG2a subclass antibodies elicited by Hexavalent recombinant protein mixture (+) Montanide ISA 50 V and control groups. The red bars represent IgG2a response and the blue bars, IgG1 response. Each bar represents the mean ± SD value of IgG2a and IgG1 responses of 11 mice from each group. Each bar represents the mean ± SD value of IgG2a and IgG1 responses of 11 mice from each group. In figure, ** represent P ≤ 0.01

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us